Chlorotrianisene

   
Google
 
Web NewDrugInformation.com

Chlorotrianisene


Drug - Chlorotrianisene
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Chlorotrianisene
Multiple ingredients are in alphabetical order.

Strength - 12MG
The potency of the active ingredient(s), Chlorotrianisene. May repeat for multiple part products.

Applicant - BANNER PHARMACAPS
The firm name holding legal responsibility for Chlorotrianisene. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 084652
The FDA assigned number to Chlorotrianisene. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Chlorotrianisene. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Chlorotrianisene was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Chlorotrianisene. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Chlorotrianisene is in. Format is RX, OTC, DISCN.

Applicant Full Name - Banner Pharmacaps Inc
The full name of the firm holding legal responsibility for the new application of Chlorotrianisene.

Chlorotrianisene